- Faculty of Health and Wellbeing, University of Central Lancashire
Professor Maree Hackett holds a fractional (one day per week) paid appointment as a Professor of Epidemiology in Faculty of Health and Wellbeing at University of Central Lancashire in the United Kingdom. Maree is Program Head, Mental Health at The George Institute for Global Health, UNSW, Sydney, Australia where she leads a program of public health and health services research focusing on developing simple, cost effective strategies (which can be integrated with other secondary prevention strategies) to prevent depression and significantly improve the outcome for people with depression and other chronic diseases. This is in concordance with her current, highly competitive, National Health and Medical Research Foundation Career Development Fellowship (Level 2) on Improving the identification, management and outcome of people with depression and other chronic diseases. She has research interests, experience and funding in Aboriginal and Torres Strait Islander health – particularly in the area of social and emotional wellbeing.
Brief outline of projects
NIHR Global Health Research Stroke Research Group (IMPROVISE) co-investigator. Multi professional group of researchers from the UK, India and Australia with expertise and interest in the addressing the Global Health Challenge of stroke in India. Health services implementation grant.
Chest Heart & Stroke Scotland funded POSITIF co-investigator. POSITIF led by colleagues in Edinburgh, Scotland aims to determine whether a brief cognitive behavioural intervention for post-stroke fatigue leads to clinically-relevant improvements in fatigue after six months.
AFFINITY Co-primary investigator Overarching academic responsibility for AFFINITY along with my co-principal investigator Professor Graeme Hankey (Perth). Randomised controlled trial of fluoxetine in 1,600 people post stroke to improve function (N=1,110 recruited). I am also a co-investigator on the FOCUS trial (UK, N=3,127, published Lancet 2019) and the EFFECTS trial (Sweden, N=1,322 recruited) which are sister trials to AFFINITY with a shared published protocol (Trials) and pre-planned prospective meta-analysis.